Keywords: gsk, pre-pandemic, bird, flu, vacc, shows, cross-immunity

GSK's pre-pandemic bird flu vacc shows cross-immunity on drifted H5N1 strains

Article | 12 March 2007

Print This

UK drug major GlaxoSmithKline says that clinical trial data from two new studies showed significant cross-immunity for its pre-pandemic avian ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in